Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine to Reduce HCW Absenteeism During COVID-19
NCT04641858Phase 4Completed
- Sponsor
- University of Southern Denmark
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by University of Southern Denmark. Started Dec 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04641858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641858.